Luo YH - Search Results

1

Erlotinib has better efficacy than gefitinib in adenocarcinoma patients without EGFR-activating mutations, but similar efficacy in patients with EGFR-activating mutations.

Wu WS, Chen YM, Tsai CM, Shih JF, Chiu CH, Chou KT, Lai SL, Wu CH, Luo YH, Huang CY, Lee YC, Perng RP, Whang-Peng J. Wu WS, et al. Among authors: luo yh. Exp Ther Med. 2012 Feb;3(2):207-213. doi: 10.3892/etm.2011.383. Epub 2011 Nov 16. Exp Ther Med. 2012. PMID: 22969870 Free PMC article.

2

Life-threatening hemoptysis due to left inferior phrenic artery to pulmonary artery fistula rescued by extracorporeal membrane oxygenation therapy.

Hsu SJ, Luo YH, Lee YC, Yang KY. Hsu SJ, et al. Among authors: luo yh. Interact Cardiovasc Thorac Surg. 2011 Feb;12(2):337-8. doi: 10.1510/icvts.2010.255265. Epub 2010 Nov 19. Interact Cardiovasc Thorac Surg. 2011. PMID: 21097453

3

Inhaled ribavirin therapy in adult respiratory syncytial virus-induced acute respiratory distress syndrome.

Luo YH, Huang CY, Yang KY, Lee YC. Luo YH, et al. Arch Bronconeumol. 2011 Jun;47(6):315-7. doi: 10.1016/j.arbres.2010.12.002. Epub 2011 Mar 21. Arch Bronconeumol. 2011. PMID: 21420217 English, Spanish.

4

Association between tumor epidermal growth factor receptor mutation and pulmonary tuberculosis in patients with adenocarcinoma of the lungs.

Luo YH, Wu CH, Wu WS, Huang CY, Su WJ, Tsai CM, Lee YC, Perng RP, Chen YM. Luo YH, et al. J Thorac Oncol. 2012 Feb;7(2):299-305. doi: 10.1097/JTO.0b013e31823c588d. J Thorac Oncol. 2012. PMID: 22173705 Free article.

5

The association between tumor epidermal growth factor receptor (EGFR) mutation and multiple primary malignancies in patients with adenocarcinoma of the lungs.

Luo YH, Ho HL, Tsai CM, Shih JF, Chiu CH, Lai SL, Lee YC, Perng RP, Whang-Peng J, Chou TY, Chen YM. Luo YH, et al. Am J Clin Oncol. 2015 Apr;38(2):147-51. doi: 10.1097/COC.0b013e318292f88c. Am J Clin Oncol. 2015. PMID: 23608835

6

Influence of chemotherapy on EGFR mutation status.

Luo YH, Chen YM. Luo YH, et al. Transl Lung Cancer Res. 2013 Dec;2(6):442-4. doi: 10.3978/j.issn.2218-6751.2013.10.12. Transl Lung Cancer Res. 2013. PMID: 25806266 Free PMC article.

7

Recent advances in the development of mutant-selective EGFR inhibitors for non-small cell lung cancer patients with EGFR-TKI resistance.

Luo YH, Chen YM. Luo YH, et al. Transl Lung Cancer Res. 2014 Dec;3(6):368-9. doi: 10.3978/j.issn.2218-6751.2014.09.07. Transl Lung Cancer Res. 2014. PMID: 25806322 Free PMC article. No abstract available.

8

A prospective study of the use of circulating markers as predictors for epidermal growth factor receptor-tyrosine kinase inhibitor treatment in pulmonary adenocarcinoma.

Luo YH, Tseng PC, Lee YC, Perng RP, Whang-Peng J, Chen YM. Luo YH, et al. Cancer Biomark. 2016;16(1):19-29. doi: 10.3233/CBM-150537. Cancer Biomark. 2016. PMID: 26484608

9

Induced Pluripotent Stem Cell-conditioned Medium Suppressed Melanoma Tumorigenicity Through the Enhancement of Natural-Killer Cellular Immunity.

Hsieh CT, Luo YH, Chien CS, Wu CH, Tseng PC, Chiou SH, Lee YC, Whang-Peng J, Chen YM. Hsieh CT, et al. Among authors: luo yh. J Immunother. 2016 May;39(4):153-9. doi: 10.1097/CJI.0000000000000117. J Immunother. 2016. PMID: 27023059

10

Spectrum of cancer risk among Taiwanese with chronic obstructive pulmonary disease.

Chiang CL, Hu YW, Wu CH, Chen YT, Liu CJ, Luo YH, Chen YM, Chen TJ, Su KC, Chou KT. Chiang CL, et al. Among authors: luo yh. Int J Clin Oncol. 2016 Oct;21(5):1014-1020. doi: 10.1007/s10147-016-0983-z. Epub 2016 May 6. Int J Clin Oncol. 2016. PMID: 27154177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

599 results

Search Page

Filters